Transdermal fentanyl allows for consistent plasma concentrations of a potent synthetic µ-opioid receptor agonist and can provide constant post-operative analgesia for up to 72 h. The aim of this study was to determine the reduction of the minimum alveolar concentration of sevofl urane (MAC SEVO ) by transdermal fentanyl in nonpregnant ewes. Nine sheep were mask induced with sevofl urane (SEVO in oxygen). MAC SEVO determinations involved electrical current applied to the lateral metacarpus as a supramaximal stimulus and measurements in duplicate. Seven days later, a fentanyl patch (75 µg/h) was applied to each sheep and 15.1 ± 1.8 h later the MAC re-determined (MAC SF ). MAC SF was 1.99 ± 0.32 %, corresponding to 25.6 ± 8.1 % reduction from MAC SEVO (P < 0.001). Transdermal fentanyl produces a signifi cant MAC SEVO -sparing effect with minimal effect on cardiovascular parameters.
INTRODUCTION
Fentanyl is a potent synthetic µ-opioid receptor agonist and commonly used analgesic in clinical veterinary practice and research settings. As humane treatment of research animals receives increasingly more attention, evaluation of treatment strategies for intra-and post-operative pain is an important subject of research interest. Transdermal administration of fentanyl, via a fentanyl patch, allows for more consistent plasma concentrations for up to 72 h compared to these of intermittent boluses of various analgesic medications [1, 2] . Systemic opioids provide intra-operative antinociception, which may result in variable reduction of the minimum alveolar concentration (MAC) of inhalant anesthetics, such as sevofl urane (SEVO). We hypothesized that the administration of transdermal fentanyl will signifi cantly reduce MAC SEVO in sheep and serve as a valuable anesthetic adjunct as has been shown in other species [3, 4] .
MATERIAL AND METHODS
Nine female non-pregnant Sardinian milk sheep, aged 5 (range 3-10) years and weighing mean (±SD) 34.0 (±3.7) kg, determined to be healthy by physical examination, hematology and serum chemistry results (data not presented), were enrolled and anesthetized twice, seven days apart. The study protocol was approved by the Institutional Animal Care and Use Committee at the University of Sassari (CIBASA; protocol number 23/052) according to Italian legislation and is compliant with all relevant national regulations and institutional policies for the care and use of animals.
The sheep were purchased from local farmers for whom each sheep's milk production span had ceased. The herd was housed collectively in an outdoor pen that provided protection from the elements by a large run-in shed. Water and hay were provided ad libitum except during standard pre-anesthetic food withdrawal times (accomplished via a mesh muzzle). All sheep were allowed a minimum two week acclimatization period between acquisition of sheep and initiation of experimental procedures. Upon completion of the study, all sheep were allowed free access to a grassed pasture and maintained as property of the University of Sassari.
Initial determinations of MAC SEVO in these sheep were part of an original SEVO MAC study [5] . Briefl y, animals were face-mask induced with SEVO in O 2 and immediately mechanically ventilated. MAC SEVO was determined in duplicate via a modifi ed "updown" protocol [6] that involved as a supramaximal noxious stimulus an electrical current (5 Hz/1 ms/50 mA) delivered to the lateral metacarpus for 60 s or until gross purposeful movement was observed.
Seven days after initial experiments, the skin surface over the medial aspect of the antebrachium was clipped, thoroughly cleaned with an antiseptic solution, and allowed to dry prior to application of a transdermal fentanyl patch (Duragesic, Janssen Pharmaceuticals; 75 µg/h). The patch was secured in place with an autoadhesive bandage. After a mean of 15.1 (±1.8) h post patch application, animals were re-anesthetized for MAC SEVO determination, again in duplicate, in the presence of fentanyl (MAC SF ) employing the same protocol as in the original MAC study.
Given that the scientifi c idea behind this study was original and no similar studies have been carried out in the past in this species with fentanyl patches and sevofl urane, there was no possibility of generating a list of feasible statistical assumptions based on previous scientifi c evidence. Therefore, the computation of an appropriate sample size could not be performed a priori. Thus, at the end of the study a post-hoc power calculation was informally carried out to confi rm inclusion of at least eight sheep for this study, in which a two-tailed t-test with power of 0.98, and an alpha error of 0.05 was applied.
All variables were tested for normal distribution by a Shapiro-Wilk test. Parametric data are reported as mean (standard deviation, ±SD) and non-parametric data are reported as median (interquartile range, IQR). Student's t test and Wilcoxon Signed-Rank test were employed for parametric and nonparametric data sets, respectively to detect statistically signifi cant differences between groups. A two-tailed P-value <0.05 was accepted as indicating statistically signifi cant differences.
RESULTS AND DISCUSSION
The mean fentanyl dose in each sheep was 2.2 (±0.28) µg/kg/h. The MAC SEVO as determined previously in this study group was 2.67 (±0.30) %. The measured MAC SF was 1.99 (±0.32) % and thus on average 25.6 (±8.1) % lower than MAC SEVO (P < 0.001). The mean heart rate recorded during MAC SF determinations (113 beats/min) was signifi cantly higher than during MAC SEVO measurements (107 beats/min), P = 0.008. Similarly, the end tidal CO 2 partial pressure was higher in MAC SEVO (43 mmHg) compared to MAC SF (41 mmHg) (P < 0.001). Invasive blood pressure recordings, temperature, or respiratory rate were not statistically different between groups. All sheep recovered smoothly upon discontinuation of SEVO administration.
The results of the current study confi rm our hypothesis that transdermal fentanyl results in a marked reduction (25.6 %) of MAC SEVO in non-pregnant adult sheep, 15 h after patch application without compromising cardiopulmonary function during anesthesia, as the differences observed in HR and ETCO 2 between groups were clinically irrelevant despite statistical signifi cance. Such a MAC-sparing effect parallels the reduction of isofl urane MAC measured in dogs (36.6 %) [3] and in cats (18 %) [4] with transdermal fentanyl and also in isofl urane-anesthetized goats during intravenous fentanyl infusion, where a 0.005 mg/kg loading dose followed by 0.005 mg/kg/h produced a 27.6 % MAC reduction [7] . While two studies have evaluated post-operative pain scores after transdermal fentanyl application in sheep [8, 9] , this is the fi rst one in sheep demonstrating an anesthetic-sparing effect of fentanyl when delivered by this route.
In comparison to studies examining MAC-sparing effects of other full µ-agonists, the magnitude of MAC reduction reported here is larger than that found with hydromorphone (7.6 %) or oxymorphone (12.4 %) in desfl urane-anesthetized sheep [10] , but similar to that observed after i.v. morphine (2 mg/kg) administration in goats (29.7 %) [11] . The variability in MAC-sparing effects may very well be the result of improper opioid dosing leading to plasma concentrations that are not equal in their effi cacy of eliciting antinociception. Not surprisingly, Dzikiti et al. demonstrated a greater MAC-sparing effect with increasing infusion rates and hence plasma levels of fentanyl [7] .
The mean fentanyl dose in the current study was 2.2 µg/kg/h, which -based on pharmacokinetic studies of transdermal fentanyl patches in sheep -likely resulted in mean serum fentanyl concentrations of approximately 1 ng/mL at 15 h after application [1, 9] . However, a review of transdermal opioids in humans emphasizes the diffi culty in assigning a fi rm concentration-effect relationship to fentanyl, as the effective plasma concentration depends on various factors including pain intensity, opioid receptor expression, nociceptive impulse traffi c, and others [2] . Additionally, trans-dermally administered fentanyl is subject to variable absorption due to differences in skin thickness, body surface temperature, and application technique [1] . Although Yackey et al. aimed to compare a dose-response effect on isofl urane MACreduction with transdermal fentanyl (25 µg/h versus 50 µg/h fentanyl patches) in cats, no difference was observed between study groups with respect to MAC-reduction nor in fentanyl plasma concentrations [4] . Therefore, future studies examining the plasma concentration-dependency of MAC-reduction after transdermal fentanyl in sheep are warranted.
In summary, the current study demonstrates that transdermal fentanyl results in a signifi cant MAC-sparing effect and is well tolerated as an adjunctive agent in SEVO anesthetized sheep. Transdermalni fentanil omogućava stalnu koncentraciju u plazmi potentnog sintetičkog agoniste µ-opioidnih receptora i može da obezbedi konstantnu post-operativnu analgeziju do 72h. Svrha ove studije je bila da odredi smanjenje minimalne alveolarne koncentracije sevolfl urana (MAC SEVO ) upotrebom transdermalnog fentanila kod negravidnih ovaca.
Devet ovaca je indukovano preko maske sa SEVO u kiseoniku. Određivanje MAC SEVO vršeno je aplikacijom električne struje na lateralni metakarpus kao supramaksimalni
